BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Jiang DK, Yao L, Wang WZ, Peng B, Ren WH, Yang XM, Yu L. TP53 Arg72Pro polymorphism is associated with esophageal cancer risk: A meta-analysis. World J Gastroenterol 2011; 17(9): 1227-1233 [PMID: 21448430 DOI: 10.3748/wjg.v17.i9.1227] [Cited by in CrossRef: 17] [Cited by in F6Publishing: 15] [Article Influence: 1.5] [Reference Citation Analysis]
Number Citing Articles
1 Thurow HS, Haack R, Hartwig FP, de Oliveira IO, Dellagostin OA, Gigante DP, Horta BL, Collares T, Seixas FK. TP53 gene polymorphism: Importance to cancer, ethnicity and birth weight in a Brazilian cohort. J Biosci 2011;36:823-31. [DOI: 10.1007/s12038-011-9147-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.7] [Reference Citation Analysis]
2 Eltahir HA, Adam AAM, Yahia ZA, Ali NF, Mursi DM, Higazi AM, Eid NA, Elhassan AM, Mohammed HS, Ibrahim ME. p53 Codon 72 arginine/proline polymorphism and cancer in Sudan. Mol Biol Rep 2012;39:10833-6. [DOI: 10.1007/s11033-012-1978-0] [Cited by in Crossref: 16] [Cited by in F6Publishing: 13] [Article Influence: 1.6] [Reference Citation Analysis]
3 Yang W, Han Y, Zhao X, Duan L, Zhou W, Wang X, Shi G, Che Y, Zhang Y, Liu J, Zhang H, Zhao Q, Hong L, Fan D. Advances in prognostic biomarkers for esophageal cancer. Expert Review of Molecular Diagnostics 2019;19:109-19. [DOI: 10.1080/14737159.2019.1563485] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
4 Bellini MF, Cadamuro AC, Succi M, Proença MA, Silva AE. Alterations of the TP53 gene in gastric and esophageal carcinogenesis. J Biomed Biotechnol. 2012;2012:891961. [PMID: 22919278 DOI: 10.1155/2012/891961] [Cited by in Crossref: 48] [Cited by in F6Publishing: 52] [Article Influence: 4.8] [Reference Citation Analysis]
5 Ivanoshchuk DE, Mikhailova SV, Kulikov IV, Maksimov VN, Voevoda MI, Romashchenko AG. CCR5, CCR2, apoE, p53, ITGB3, and HFE gene polymorphism in Western Siberian long livers. Adv Gerontol 2013;3:89-92. [DOI: 10.1134/s2079057013020082] [Cited by in Crossref: 3] [Article Influence: 0.3] [Reference Citation Analysis]
6 Cao J, Chen Z, Tian C, Yu J, Zhang H, Yang J, Yang W. A Shared Susceptibility Locus in the p53 Gene for both Gastric and Esophageal Cancers in a Northwestern Chinese Population. Genet Test Mol Biomarkers 2020;24:804-11. [PMID: 33290139 DOI: 10.1089/gtmb.2020.0192] [Reference Citation Analysis]
7 Li J, Liu X, Qiao Y, Qi R, Liu S, Guo J, Gui Y, Li J, Yu H. Association Between Genetic Variant in the Promoter of Pri-miR-34b/c and Risk of Glioma. Front Oncol 2018;8:413. [PMID: 30319976 DOI: 10.3389/fonc.2018.00413] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
8 Zhuo W, Zhang L, Wang Y, Zhu B, Chen Z. Cyclin D1 G870A polymorphism is a risk factor for esophageal cancer among Asians. Cancer Invest. 2012;30:630-636. [PMID: 23020291 DOI: 10.3109/07357907.2012.726385] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 0.9] [Reference Citation Analysis]
9 Bayram S, Rencüzoğulları E, Almas AM, Genç A. Effect of p53 Arg72Pro polymorphism on the induction of micronucleus by aflatoxin B1 in in vitro in human blood lymphocytes. Drug and Chemical Toxicology 2016;39:331-7. [DOI: 10.3109/01480545.2015.1121275] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
10 Zhang H, Hao S, Zhao J, Zhou B, Ren Y, Yan Y, Zhao Y. Common genetic variants in 53BP1 associated with nonsmall-cell lung cancer risk in Han Chinese. Arch Med Res 2014;45:84-9. [PMID: 24316395 DOI: 10.1016/j.arcmed.2013.10.011] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
11 Renouf DJ, Zhai R, Sun B, Xu W, Cheung WY, Heist RS, Kulke MH, Cescon D, Asomaning K, Marshall AL, Li S, Christiani DC, Liu G. Association of MDM2 T309G and p53 Arg72Pro polymorphisms and gastroesophageal reflux disease with survival in esophageal adenocarcinoma. J Gastroenterol Hepatol 2013;28:1482-8. [PMID: 23735059 DOI: 10.1111/jgh.12286] [Cited by in Crossref: 10] [Cited by in F6Publishing: 7] [Article Influence: 1.3] [Reference Citation Analysis]
12 Brunotto M, Zarate AM, Bono A, Barra JL, Berra S. Risk genes in head and neck cancer: a systematic review and meta-analysis of last 5 years. Oral Oncol 2014;50:178-88. [PMID: 24370206 DOI: 10.1016/j.oraloncology.2013.12.007] [Cited by in Crossref: 33] [Cited by in F6Publishing: 31] [Article Influence: 3.7] [Reference Citation Analysis]
13 Sarkar J, Dominguez E, Li G, Kusewitt DF, Johnson DG. Modeling gene-environment interactions in oral cavity and esophageal cancers demonstrates a role for the p53 R72P polymorphism in modulating susceptibility. Mol Carcinog 2014;53:648-58. [PMID: 23475592 DOI: 10.1002/mc.22019] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
14 Shen SQ, Jiang DK, Liu GY, Chen F, Yu L. Meta-analysis shows significant association of the TP53 Arg72Pro with ovarian cancer risk. Mol Biol Rep 2012;39:4683-90. [PMID: 21952824 DOI: 10.1007/s11033-011-1260-x] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 0.6] [Reference Citation Analysis]
15 Djansugurova LB, Perfilyeva AV, Zhunusova GS, Djantaeva KB, Iksan OA, Khussainova EM. The determination of genetic markers of age-related cancer pathologies in populations from Kazakhstan. Front Genet. 2013;4:70. [PMID: 23675381 DOI: 10.3389/fgene.2013.00070] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 1.3] [Reference Citation Analysis]